CA2281473A1 - Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same - Google Patents
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same Download PDFInfo
- Publication number
- CA2281473A1 CA2281473A1 CA002281473A CA2281473A CA2281473A1 CA 2281473 A1 CA2281473 A1 CA 2281473A1 CA 002281473 A CA002281473 A CA 002281473A CA 2281473 A CA2281473 A CA 2281473A CA 2281473 A1 CA2281473 A1 CA 2281473A1
- Authority
- CA
- Canada
- Prior art keywords
- methods
- dosage form
- manufacture
- same
- form exhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 230000001747 exhibiting effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
Abstract
A rapidly dispersing dosage form is described, which releases its active ingredients within a period of less than about ninety seconds.
These dosage forms exhibit a three-dimensional shape that is retained for adequate storage but is readily dispersed in the presence of excess moisture. Also disclosed are methods of administration of a medicament and a process for the preparation of rapidly dispersing dosage forms.
These dosage forms exhibit a three-dimensional shape that is retained for adequate storage but is readily dispersed in the presence of excess moisture. Also disclosed are methods of administration of a medicament and a process for the preparation of rapidly dispersing dosage forms.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3888397P | 1997-02-20 | 1997-02-20 | |
US3828497P | 1997-02-20 | 1997-02-20 | |
US60/038,284 | 1997-02-20 | ||
US60/038,883 | 1997-02-20 | ||
PCT/US1998/003256 WO1998036738A1 (en) | 1997-02-20 | 1998-02-20 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2281473A1 true CA2281473A1 (en) | 1998-08-27 |
CA2281473C CA2281473C (en) | 2007-01-16 |
Family
ID=26715043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002281473A Expired - Lifetime CA2281473C (en) | 1997-02-20 | 1998-02-20 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
Country Status (9)
Country | Link |
---|---|
US (3) | US6471992B1 (en) |
EP (1) | EP0973507B1 (en) |
JP (3) | JP4563516B2 (en) |
AT (1) | ATE421318T1 (en) |
AU (1) | AU736912B2 (en) |
CA (1) | CA2281473C (en) |
DE (1) | DE69840495D1 (en) |
ES (1) | ES2318869T3 (en) |
WO (1) | WO1998036738A1 (en) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU736912B2 (en) * | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
WO1999059544A2 (en) * | 1998-05-18 | 1999-11-25 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
US6284270B1 (en) * | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
AU2001273687A1 (en) * | 2000-07-10 | 2002-01-21 | Massachusetts Institute Of Technology | Method and materials for controlling migration of binder liquid in a powder |
IL159287A0 (en) * | 2001-06-28 | 2004-06-01 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
JP4426286B2 (en) * | 2001-07-10 | 2010-03-03 | テバ ファーマシューティカル インダストリーズ リミティド | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug release |
WO2003041690A2 (en) * | 2001-10-29 | 2003-05-22 | Therics, Inc. | Three-dimensional suspension printing of dosage forms |
WO2003037607A1 (en) * | 2001-10-29 | 2003-05-08 | Therics, Inc. | A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
EP1503741B1 (en) | 2002-05-06 | 2008-09-10 | Massachusetts Institute Of Technology | Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
MXPA05005528A (en) | 2002-11-26 | 2006-04-05 | Alk Abello As | Pharmaceutical allergen product. |
JP5049129B2 (en) | 2004-09-21 | 2012-10-17 | ハイプニオン・インコーポレイテッド | Loxapine analogs and methods for their use |
US7829000B2 (en) * | 2005-02-25 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Core-shell solid freeform fabrication |
US8187659B2 (en) | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
DK2041071T3 (en) | 2006-06-29 | 2014-09-01 | Kinex Pharmaceuticals Llc | BIARLYL COMPOSITIONS AND PROCEDURES FOR MODULATING A CHINA CASE |
CN105796568A (en) | 2007-10-20 | 2016-07-27 | 阿西纳斯公司 | Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
PL2493457T3 (en) | 2009-10-30 | 2018-01-31 | Ix Biopharma Ltd | Fast dissolving solid dosage form |
WO2011123180A1 (en) * | 2010-04-03 | 2011-10-06 | Praful Doshi | Medical devices including medicaments and methods of making and using same |
EP2632920A1 (en) | 2010-10-27 | 2013-09-04 | Dynamix Pharmaceuticals Ltd. | Sulfonamides for the modulation of pkm2 |
US8987271B2 (en) | 2010-12-22 | 2015-03-24 | Eutropics Pharmaceuticals, Inc. | 2,2′-biphenazine compounds and methods useful for treating disease |
US8722636B2 (en) | 2011-01-31 | 2014-05-13 | New Market Pharmaceuticals, LLC | Animal treatments |
US9051305B2 (en) | 2011-03-08 | 2015-06-09 | Eutropics Pharmaceuticals, Inc. | Compositions and methods useful for treating diseases |
ITMI20110793A1 (en) | 2011-05-09 | 2012-11-10 | Probiotical Spa | STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD. |
ITMI20110791A1 (en) | 2011-05-09 | 2012-11-10 | Probiotical Spa | BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES. |
ITMI20110792A1 (en) | 2011-05-09 | 2012-11-10 | Probiotical Spa | STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA. |
US20120302609A1 (en) | 2011-05-25 | 2012-11-29 | Dynamix Pharmaceuticals Ltd. | Pyrazolines for the Modulation of PKM2 |
ES2585244T3 (en) | 2011-06-07 | 2016-10-04 | Clevexel Pharma | Compositions and methods to modulate a kinase |
ITMI20111718A1 (en) | 2011-09-23 | 2013-03-24 | Probiotical Spa | A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS. |
US9245061B2 (en) * | 2012-04-25 | 2016-01-26 | Shapeways, Inc. | Weight-based identification of three dimensional printed parts |
AU2012379005B2 (en) | 2012-05-02 | 2017-12-21 | Newmarket Pharmaceuticals Llc | Pharmaceutical compositions for direct systemic introduction |
US20150150869A1 (en) | 2012-06-20 | 2015-06-04 | Eutropics Pharmaceuticals, Inc. | Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
WO2014116770A1 (en) * | 2013-01-23 | 2014-07-31 | Arx, Llc | Production of unit dose constructs |
MX365914B (en) | 2013-03-15 | 2019-06-20 | Aprecia Pharmaceuticals LLC | Rapidly dispersible dosage form of topiramate. |
WO2014143935A1 (en) * | 2013-03-15 | 2014-09-18 | Aprecia Pharmaceuticals Company | Rapidly dispersible dosage form of oxcarbazepine |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
EP2968994B1 (en) | 2013-03-15 | 2018-08-15 | Aprecia Pharmaceuticals LLC | Rapid disperse dosage form containing levetiracetam |
WO2014176389A1 (en) | 2013-04-24 | 2014-10-30 | Temple University - Of The Commonwealth System Of Higher Education | Solid dosage form containing arabinogalactan |
ITMI20130793A1 (en) | 2013-05-14 | 2014-11-15 | Probiotical Spa | COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES. |
WO2015023729A1 (en) | 2013-08-16 | 2015-02-19 | The Exone Company | Three-dimensional printed metal-casting molds and methods for making the same |
WO2015057761A1 (en) | 2013-10-17 | 2015-04-23 | The Exone Company | Three-dimensional printed hot isostatic pressing containers and processes for making same |
US20160325495A1 (en) * | 2013-12-23 | 2016-11-10 | The Exone Company | Methods and Systems for Three-Dimensional Printing Utilizing a Jetted-Particle Binder Fluid |
ES2745763T3 (en) | 2013-12-23 | 2020-03-03 | The Exone Co | Methods and systems for three-dimensional printing using multiple binder fluids |
EP3086922B1 (en) | 2013-12-23 | 2022-03-09 | The Exone Company | Method of three-dimensional printing using a multi-component build powder |
US20160184230A1 (en) * | 2014-04-30 | 2016-06-30 | Aron H. Blaesi | Melt-processed polymeric cellular dosage form |
WO2015183796A1 (en) | 2014-05-29 | 2015-12-03 | The Exone Company | Process for making nickel-based superalloy articles by three-dimensional printing |
WO2016011098A2 (en) | 2014-07-17 | 2016-01-21 | The Exone Company | Methods and apparatuses for curing three-dimensional printed articles |
CN107249567B (en) | 2014-11-21 | 2021-08-03 | 拜尔哈文制药股份有限公司 | Sublingual administration of riluzole |
US20180001551A1 (en) | 2014-12-03 | 2018-01-04 | The Exone Company | Process for Making Densified Carbon Articles by Three Dimensional Printing |
CA2987114A1 (en) | 2015-06-03 | 2016-12-08 | Triastek, Inc. | Method of 3d printing oral dosage forms having a drug in a compartment sealed by an erodibleplug |
EP3108874A1 (en) * | 2015-06-26 | 2016-12-28 | TRB Chemedica AG | Ophthalmologic pharmaceutical composition |
US11129798B2 (en) * | 2016-08-19 | 2021-09-28 | Aron H. Blaesi | Fibrous dosage form |
JP2019508449A (en) * | 2016-03-18 | 2019-03-28 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Combinations of drugs with various effects |
JPWO2017175792A1 (en) * | 2016-04-06 | 2019-02-14 | アステラス製薬株式会社 | Fast-eluting three-dimensional structure, fast-eluting three-dimensional structure filament and fast-eluting three-dimensional structure material |
CN107847398B (en) | 2016-05-05 | 2019-05-07 | 南京三迭纪医药科技有限公司 | Control the pharmaceutical dosage form of release |
EP3458053B1 (en) | 2016-05-20 | 2021-12-08 | Biohaven Pharmaceutical Holding Company Ltd. | Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers |
US10213435B2 (en) | 2016-08-12 | 2019-02-26 | Athenex, Inc. | Biaryl compositions and methods for modulating a kinase cascade |
EP3529023B1 (en) | 2016-10-19 | 2022-05-25 | Shapeways, Inc. | Systems and methods for identifying three-dimensional printed objects |
KR20240031326A (en) | 2016-12-31 | 2024-03-07 | 바이오엑셀 테라퓨틱스 인코포레이티드 | Use of Sublingual Dexmedetomidine for the treatment of Agitation |
WO2018156141A1 (en) * | 2017-02-24 | 2018-08-30 | Hewlett-Packard Development Company, L.P. | Three-dimensional (3d) printing a pharmaceutical tablet |
ES2958616T3 (en) | 2017-03-08 | 2024-02-12 | Cinrx Pharma Llc | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol |
WO2018218203A1 (en) | 2017-05-26 | 2018-11-29 | Philip Brunner | Water soluble polymer compositions |
US20210023061A1 (en) | 2017-11-12 | 2021-01-28 | Biohaven Pharmaceutical Holding Company Ltd. | Use of riluzole prodrugs to treat ataxias |
CN108066302B (en) * | 2017-12-28 | 2020-09-11 | 无限极(中国)有限公司 | Preparation method of fast-dispersing solid preparation and fast-dispersing solid preparation prepared by same |
US11571391B2 (en) | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
US10350822B1 (en) | 2018-01-09 | 2019-07-16 | Triastek Inc. | Dosage forms with desired release profiles and methods of designing and making thereof |
DE102018107585B3 (en) * | 2018-03-29 | 2019-03-28 | Universität Rostock | Device for producing 3D printed drug delivery systems with drug depots, and methods for manufacturing 3D printed drug delivery systems |
CA3103431A1 (en) | 2018-06-27 | 2020-01-02 | Bioxcel Therapeutics, Inc. | Film formulations containing dexmedetomidine and methods of producing them |
JP2022508714A (en) | 2018-10-15 | 2022-01-19 | アプレシア・ファーマスーティカルズ・エルエルシー | Methods and systems for forming dosage forms in packaging |
EP3883546A1 (en) | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
JP7287032B2 (en) | 2019-03-20 | 2023-06-06 | 株式会社リコー | SHEET, SHEET LAMINATED PRODUCT, PHARMACEUTICAL, SHEET MANUFACTURING METHOD, AND SHEET LAMINATED MANUFACTURING METHOD |
CN113891706A (en) * | 2019-05-21 | 2022-01-04 | 迪辅益制药有限及两合公司 | Lactose powder bed three-dimensional printing |
CA3145388A1 (en) | 2019-07-19 | 2021-01-28 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
TWI734309B (en) * | 2019-12-19 | 2021-07-21 | 水星生醫股份有限公司 | Permeable spraying device for making tablets |
JP2023533478A (en) | 2020-06-26 | 2023-08-03 | アプレシア・ファーマスーティカルズ・エルエルシー | Rapidly dispersible tablet with internal cavity |
TW202224672A (en) | 2020-10-30 | 2022-07-01 | 大陸商南京三迭紀醫藥科技有限公司 | Gastroretentive pharmaceutical dosage form |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5206025A (en) | 1989-05-24 | 1993-04-27 | Rhone-Poulenc Sante | Porous pharmaceutical form and its preparation |
FR2647343B1 (en) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | NOVEL POROUS PHARMACEUTICAL FORM AND ITS PREPARATION |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
US5204055A (en) | 1989-12-08 | 1993-04-20 | Massachusetts Institute Of Technology | Three-dimensional printing techniques |
US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
ES2081564T3 (en) | 1991-01-31 | 1996-03-16 | Texas Instruments Inc | METHOD AND SYSTEM FOR THE MANUFACTURE, CONTROLLED BY COMPUTER, OF THREE-DIMENSIONAL OBJECTS FROM COMPUTER DATA. |
JP2614409B2 (en) | 1991-12-20 | 1997-05-28 | ファイザー・インコーポレーテッド | Porous shaped release formulation and method of making same |
JP2521612B2 (en) * | 1992-05-20 | 1996-08-07 | ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド | Direct tablet forming aid |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
DE4303846A1 (en) * | 1993-02-10 | 1994-08-11 | Merck Patent Gmbh | Process for the preparation of a tablet containing S-ibuprofen |
ATE208615T1 (en) | 1993-07-09 | 2001-11-15 | Scherer Corp R P | METHOD FOR PRODUCING FREEZE-DRIED MEDICINAL DOSAGE FORMS |
US6176874B1 (en) | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
US6280771B1 (en) | 1997-02-20 | 2001-08-28 | Therics, Inc. | Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof |
US5490962A (en) | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US5503785A (en) | 1994-06-02 | 1996-04-02 | Stratasys, Inc. | Process of support removal for fused deposition modeling |
US5633021A (en) | 1994-10-19 | 1997-05-27 | Bpm Technology, Inc. | Apparatus for making a three-dimensional article |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
US5560927A (en) * | 1995-07-28 | 1996-10-01 | Isp Investments Inc. | Co-processing method for making a free-flowing compressible powder and tablet therefrom |
US5653925A (en) * | 1995-09-26 | 1997-08-05 | Stratasys, Inc. | Method for controlled porosity three-dimensional modeling |
AU736912B2 (en) * | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
DE19940944B4 (en) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retarded, oral, pharmaceutical dosage forms |
-
1998
- 1998-02-20 AU AU63314/98A patent/AU736912B2/en not_active Ceased
- 1998-02-20 JP JP53687898A patent/JP4563516B2/en not_active Expired - Lifetime
- 1998-02-20 US US09/027,183 patent/US6471992B1/en not_active Expired - Lifetime
- 1998-02-20 CA CA002281473A patent/CA2281473C/en not_active Expired - Lifetime
- 1998-02-20 WO PCT/US1998/003256 patent/WO1998036738A1/en active Search and Examination
- 1998-02-20 AT AT98907531T patent/ATE421318T1/en not_active IP Right Cessation
- 1998-02-20 ES ES98907531T patent/ES2318869T3/en not_active Expired - Lifetime
- 1998-02-20 DE DE69840495T patent/DE69840495D1/en not_active Expired - Lifetime
- 1998-02-20 EP EP98907531A patent/EP0973507B1/en not_active Expired - Lifetime
-
2002
- 2002-07-19 US US10/200,029 patent/US9463160B2/en not_active Expired - Fee Related
-
2009
- 2009-05-11 JP JP2009114753A patent/JP5091910B2/en not_active Expired - Lifetime
- 2009-11-09 JP JP2009256374A patent/JP2010120938A/en not_active Withdrawn
-
2012
- 2012-02-09 US US13/369,473 patent/US9114072B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0973507A4 (en) | 2006-08-23 |
DE69840495D1 (en) | 2009-03-12 |
ES2318869T3 (en) | 2009-05-01 |
US9463160B2 (en) | 2016-10-11 |
EP0973507B1 (en) | 2009-01-21 |
US20030133975A1 (en) | 2003-07-17 |
JP4563516B2 (en) | 2010-10-13 |
JP2010120938A (en) | 2010-06-03 |
AU6331498A (en) | 1998-09-09 |
WO1998036738A1 (en) | 1998-08-27 |
US6471992B1 (en) | 2002-10-29 |
JP2009215305A (en) | 2009-09-24 |
ATE421318T1 (en) | 2009-02-15 |
JP5091910B2 (en) | 2012-12-05 |
AU736912B2 (en) | 2001-08-02 |
EP0973507A1 (en) | 2000-01-26 |
US9114072B2 (en) | 2015-08-25 |
US20120207929A1 (en) | 2012-08-16 |
JP2001512488A (en) | 2001-08-21 |
CA2281473C (en) | 2007-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2281473A1 (en) | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
HUT55220A (en) | Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient | |
CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
CA2339765A1 (en) | Compounds and compositions for delivering active agents | |
CA2087146A1 (en) | Flavour-masked pharmaceutical compositions | |
HUT61031A (en) | Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient | |
CA2154424A1 (en) | 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect | |
CA2015536A1 (en) | Pharmaceutical formulation | |
RU94046268A (en) | Omeprazole granules and method of their preparing | |
CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
CA2232450A1 (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
HU0301171D0 (en) | Antifungal active ingredients, pharmaceutical compositions containing the same and process for their preparation | |
HUP9903613A3 (en) | Improvement in the taste of active pharmaceutical ingredients | |
HUT58511A (en) | Process for producing pharmaceutical compositions comprising toremifen and its metabolites, suitable for ceasing the simultaneous resistance of cancer cells to several cytotoxic active ingredients | |
AU2034395A (en) | Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the active substance | |
HUT53873A (en) | Insecticides comprising nitro compounds as active ingredient and process for producing the active ingredients | |
HK1005224A1 (en) | Use of complex lipide as stabilizing additives in pharmaceutical formulation of digestive enzyme mixture. | |
CA2143413A1 (en) | Local Drug Delivery Film, for Periodontal Treatment | |
HUP9900365A3 (en) | N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients | |
CA2000932A1 (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
DE2966411D1 (en) | Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions | |
CA2294448A1 (en) | Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins | |
HUT48217A (en) | Pesticides comprising 5-methylamino-1-arylpyrazole derivatives as active ingredient and process for producing the active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20180220 |